已收录 268918 条政策
 政策提纲
  • 暂无提纲
Human antibody VH domains targeting uPAR as candidate therapeutics for cancers
[摘要] The high expression of uPAR has been linked to tumor progression, invasion, and metastasis in several types of cancer. Such overexpression of uPAR makes it a potential target for immunotherapies across common cancers such as breast, colorectal, lung, ovarian cancer, and melanoma. In our study, two high-affinity and specific human VH domain antibody candidates, designed as clones 3 and 115, were isolated from a phage-displayed human VH antibody library. Domain-based bispecific T- cell engagers (DbTE) based on these two antibodies exhibited potent killing of uPAR-positive cancer cells. Thus, these two anti-uPAR domain antibodies are promising candidates for treating uPAR positive cancers.
[发布日期] 2023-10-09 [发布机构] 
[效力级别]  [学科分类] 
[关键词] therapeutic antibody;VH domain;human uPAR;DbTE (domain based bispecific T cell engager);cancer [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文